Bringing together luminary educators across a variety of subspecialties, this Categorical Course will deliver the latest imaging information concerning lung, colorectal, and breast cancer. Participants will gain the interpretive, technical, and systems knowledge radiologists need to provide quality screening, while learning strategies to address overall care disparities. Providing a truly comprehensive review of oncologic imaging, additional discussions will address diagnostic workflows, enterprise solutions, new horizons in PET/MRI, and the role of AI. Response assessment criteria, including RECIST 1.1, iRECIST, and Lugano, as well as business models for establishing a response assessment lab will also be discussed.
Judy Yee, MD
Montefiore Medical Center, NY
Debra S. Copit, MD
Wynnewood and Philadelphia, PA
Efren J. Flores, MD
Massachusetts General Hospital
Jonathan G. Goldin, MD, MBChB, PhD
UCLA/David Geffen School of Medicine
Upon completion of this course, participants will be able to:
Each registrant will receive the accompanying book, featuring a corresponding chapter for each scheduled presentation. An electronic copy of the book is also included. Individuals who register for this course after March 17, 2022 will receive the hard copy of the book after the Annual Meeting takes place. To receive the book to use with the Categorical Course, be sure to register prior to March 17, 2022.
Due to the nature and granularity of this course, a separate registration fee is required, in addition to your general registration fee.
ARRS is accredited by the Accreditation Council of Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
The ARRS designates this live activity for a maximum of 18 AMA PRA Category 1 Credit(s) and 18 American Board of Radiology©, MOC Part II, Self-Assessment (SAM) credits. Physicians should claim only the credit commensurate with the extent of their participation in an activity.